Seizures in patients with primary brain tumors: what is their psychosocial impact?

Journal of Neuro-Oncology

Volumn 128, Issue 2, 2016, Pages 285-291

  Shin, John Y ^a   Kizilbash, Sani H ^a   Robinson, Steven I ^a   Uhm, Joon H ^a   Hammack, Julie E ^a   Lachance, Daniel H ^a   Buckner, Jan C ^a   Jatoi, Aminah ^a  

^a MAYO CLINIC   (United States)

Author keywords

Brain tumors; Qualitative; Quality of life; Seizures; Symptoms

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH IMPACT ASSESSMENT; HUMAN; MALE; PRIMARY TUMOR; QUALITATIVE ANALYSIS; QUALITY OF LIFE; SEIZURE; SEMI STRUCTURED INTERVIEW; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; COMPLICATION; INTERVIEW; MIDDLE AGED; PSYCHOLOGY; QUALITATIVE RESEARCH;

ANTICONVULSIVE AGENT;

ADULT; AGED; ANTICONVULSANTS; BRAIN NEOPLASMS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; QUALITATIVE RESEARCH; QUALITY OF LIFE; SEIZURES;

EID: 84961135536     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-016-2108-y     Document Type: Article

References (29)

1. Shah U, Morrison T (2013) A review of the symptomatic management of malignant gliomas in adults. J Natl Compr Cancer Netw 11:424–429
2. Michelucci R, Pasini E, Meletti S et al (2013) Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study—project of Emilia Romagna region on neuro-oncology). Epilepsia 54(Supple 7):86–91
3. Wick W, Menn O, Meisner C et al (2005) Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie 28:391–396
4. Van Breemen MS, Rijsman RM, Taphoorn MJ et al (2009) Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 256:1519–1526
5. Ruge MI, Ilmberger J, Tonn JC, Kreth FW (2011) Health-related quality of life and cognitive functioning in adult patients with supratentorial WHO grade II glioma: status prior to therapy. J Neurooncol 103:129–136
6. Rahman Z, Wong CH, Dexter M et al (2015) Epilepsy in patients with primary brain tumors: the impact on mood, cognition, and HRQOL. Epilepsy Behav 48:88–95
7. Sato I, Higuchi A, Yanagisawa T et al (2014) Impact of late effects on health-related quality of life in survivors of pediatric brain tumors: motility disturbance of limbs, seizure, ocular/visual impairment, endocrine abnormality, and higher brain dysfunction. Cancer Nurs 37:E1–E14
8. Greenhalgh T, Annandale E, Ashccroft R et al (2016) An open letter to the BMJ editors on qualitative research. BMJ 352:i563
9. Hersch J, Jansen J, Baratt A et al (2013) Women’s views on overdiagnosis in breast cancer screening: a qualitative study. BMJ 346:f158
10. Curry LA, Spatz E, Cherlin E et al (2011) What distinguishes top-performing hospitals in acute myocardial infarction mortality rates? Ann Intern Med 154:384–390
11. Brooks GA, Abrams TA, Meyerhardt JA et al (2014) Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol 32:496–503
12. Miller VA, Cousino M, Leek AC, Kodish ED (2014) Hope and persuasion by physicians during informed consent. J Clin Oncol 32:3229–3235
13. Volk ML, Biggins SW, Huang MA et al (2011) Decision making in liver transplant selection committees. Ann Intern Med 155:503–508
14. Pope C, Ziebland S, Mays N (2000) Qualitative research in health care. Analysing qualitative data. BMJ 320:114–116
15. Meyer J (2000) Qualitative research in health care. Using qualitative methods in health related action research. BMJ 320:50–52
16. Green J, Britten N (1997) Qualitative research and evidence based medicine. BMJ 315:740–743
17. Britten N (1995) Qualitative interviews in medical research. BMJ 311:251–253
18. May N, Pope C (1995) Rigour and qualitative research. BMJ 311:109–112
19. http://www.tandfonline.com/doi/abs/10.1191/1478088706qp063oa#.VsO8ZNj2ZaQ. Accessed 16 Feb 2016
20. Hewitt ME, Bamundo A, Day R, Harvey C (2007) Perspectives on post-treatment cancer care: qualitative research with survivors. J Clin Oncol 25:1691–1697
21. Wager E, Williams P (2013) “Hardly worth the effort”? Medical journals’ policies and their editors’ and publishers’ views on trial registration and publication bias: quantitative and qualitative study. BMJ 347:5248
22. Honda M, Wakita T, Onishi Y et al (2015) Development and validation of a disease-specific instrument to measure diet-targeted quality of life for postoperative patients with esophagogastric cancer. Ann Surg Oncol 22:848–854
23. Osbourne TR, Ramsenthaler C, Schey SA et al (2015) Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the myeloma outcome scale (MyPOS). BMC Cancer 15:280
24. Sepucha KR, Feibelmann S, Cosenza C et al (2014) Development and evaluation of a new survey instrument to measure the quality of colorectal cancer screening decisions. BMC Med Inform Decis Mak 14:72
25. De Souza JA, Yap BJ, Hlubocky FJ et al (2014) The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer 120:3245–3253
26. King MT, Stockler MR, Butow P et al (2014) Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer. Int J Gynecol Cancer 24:865–873
27. Winters ZE, Balta V, Thomson HK et al (2014) Phase III development of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire module for women undergoing breast reconstruction. Br J Surg 101:371–382
28. Williams LA, Agarwal S, Bodurka DC et al (2013) Capturing the patient’s experience: using qualitative research methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer. J Pain Symptom Manag 46:837–845
29. Flynn KE, Lin L, Cyranowski JM et al (2013) Development of the NIH PROMIS sexual function and satisfaction measures in patients with cancer. J Sex Med 10(Suppl 1):43–52